NCT03520270

Brief Summary

A multicenter point prevalence study in Turkish intensive care units.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,128

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 9, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

October 15, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2018

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
Last Updated

March 1, 2019

Status Verified

February 1, 2019

Enrollment Period

1 month

First QC Date

April 13, 2018

Last Update Submit

February 28, 2019

Conditions

Critical IllnessTerminal IllnessPotentially Inappropriate Medication List

Outcome Measures

Primary Outcomes (1)

  • Prevalence of terminal patients in the ICU

    Investigation of the number of terminal patients treated in the intensive care units at the last days of life

    1 day

Secondary Outcomes (1)

  • Resource use

    1 day

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All intensive care patients fulfilling eligibility criteria

You may qualify if:

  • All patients who are over 18 years old, more than 48 hours in the intensive care unit, or expected to be hospitalized

You may not qualify if:

  • Patients under 18 years of age, less than 48 hours in the intensive care unit stay, or who are monitorized for post-operative care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University Cerrahpasa Medical School

Istanbul, Turkey (Türkiye)

Location

Related Publications (2)

  • Nelson JE, Bassett R, Boss RD, Brasel KJ, Campbell ML, Cortez TB, Curtis JR, Lustbader DR, Mulkerin C, Puntillo KA, Ray DE, Weissman DE; Improve Palliative Care in the Intensive Care Unit Project. Models for structuring a clinical initiative to enhance palliative care in the intensive care unit: a report from the IPAL-ICU Project (Improving Palliative Care in the ICU). Crit Care Med. 2010 Sep;38(9):1765-72. doi: 10.1097/CCM.0b013e3181e8ad23.

    PMID: 20562699RESULT

  • Shreves A, Marcolini E. End of life/palliative care/ethics. Emerg Med Clin North Am. 2014 Nov;32(4):955-74. doi: 10.1016/j.emc.2014.07.010. Epub 2014 Sep 16.

    PMID: 25441045RESULT

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 13, 2018

First Posted

May 9, 2018

Study Start

October 15, 2018

Primary Completion

November 14, 2018

Study Completion

November 30, 2018

Last Updated

March 1, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)